Sales of counterfeit drugs rose during the pandemic

0



From Rajendra Diwe:

One report said: “Inferior, Mislabeled, Counterfeit and Counterfeit (SSFFC) incidents increased 20% between 2018 and 2020 and 17% between 2019 and 2020. Incidents reported in these sectors account for over 84% of all counterfeiting. “

The Covid-19 pandemic has led to an increase in incidents of substandard, false, mislabeled, counterfeit and counterfeit (SSFFC) in pharmaceuticals and medical devices, according to a report published by Pharmabiz. According to Pharmabiz’s e-pharmail, “global enforcement agencies, including Interpol, have seen an increase in incidents of substandard, false, mislabeled, counterfeit and counterfeit (SSFFC) drugs and medical devices. The Covid-19 pandemic triggered such scams because of the unprecedented demand for drugs. “The report quotes Nakul Pasricha, President of the Authentication Solution Providers’ Association (ASPA):” It has been observed that criminals are the high demand for drugs, nutritional supplements , Hygiene products and other essential products.

The scammers have contaminated the market by selling counterfeit and substandard products that threaten the lives of doctors and patients. In India, after alcohol, tobacco, FMCG-packaged goods and currencies, pharmaceuticals are among the five most vulnerable categories. “Incidents of counterfeiting increased by 20% between 2018 and 2020 and by 17% between 2019 and 2020. Incidents reported in these sectors account for over 84 percent of all counterfeiting, ”the report said. “The government must ensure that consumers are not being scammed with counterfeit drugs and medical devices. We “The government must ensure that consumers are not being scammed with counterfeit medicines and medical devices.

We recommend that the government raise awareness of counterfeits. Law enforcement personnel must be empowered and trained to be vigilant and take action against those who sell counterfeit products. In addition, real manufacturers of high-demand drugs should be incentivized to reduce scarcity and keep counterfeiters at bay, ”added ASPA President. In the area of ​​counterfeiting, according to the Annual Special 301 Report of USTR, India remains on the USTR’s “Priority Watch List” due to a lack of adequate protection and enforcement of intellectual property rights. Others are Algeria, Argentina, Chile, China, Indonesia, Russia, Saudi Arabia, Ukraine, and Venezuela. It is estimated that counterfeits cost the Indian economy over 1 trillion rupees annually. It is also becoming increasingly difficult to detect such scams as counterfeiters become smarter as technologies are used to reproduce packaging.

These double packs are almost identical to the original, which only a trained and careful eye can see. Considerable attention is required to identify any signs of tampering with the packaging. However, we see that a bit of care and attention would make a world of difference, Pasricha told Pharmabiz. The Drugs and Cosmetics Act prescribes the monitoring of SSFFC as a joint responsibility of the central and state drug control authorities. Even consumers can monitor counterfeit or substandard medicines and report them to drug authorities. Technology, including smartphones, can use the Internet to verify the authenticity of products. Phygital authentication solutions: holograms, QR codes, unique identification numbers on barcodes are inexpensive and make it extremely easy to detect counterfeit products and report fraud.

Another technically integrated authentication effectively tracks the location of the theft in the supply chain. Combining physical and digital technologies, he said. To build and maintain a robust authentication ecosystem, ASPA has put in place awareness-raising activities and advice for the industry to take action to combat counterfeit products. It has signed a MoU with GS1 India to disseminate information on global standards for counterfeit detection and control. It has a fake news archive of Indian counterfeiting incidents and is about to release the first edition of the Authentication & Traceability Source Guide. The government must ensure that authentication practices are enforced for their Make in India initiative, as trust is a critical factor as medicines that are exported must be genuine, safe and secure until they are shipped to end users around the world said Pasricha.



Share.

Comments are closed.